Correlation Between Tumor Regression and T Cell Responses in Melanoma Patients Vaccinated With a MAGE Antigen

Proceedings of the National Academy of Sciences of the United States of America - United States
doi 10.1073/pnas.0405743101
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Proceedings of the National Academy of Sciences

Related search

Monoclonal Anti-Mage-3 CTL Responses in Melanoma Patients Displaying Tumor Regression After Vaccination With a Recombinant Canarypox Virus

Journal of Immunology
AllergyImmunology
2003English

Autoimmunity Correlates With Tumor Regression in Patients With Metastatic Melanoma Treated With Anti–Cytotoxic T-Lymphocyte Antigen-4

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2005English

Oncolytic Measles Virus Therapy Enhances Tumor Antigen-Specific T-Cell Responses in Patients With Multiple Myeloma

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2020English

Spontaneous Peripheral T-Cell Responses Toward the Tumor-Associated Antigen Cyclin D1 in Patients With Clear Cell Renal Cell Carcinoma

Cancer immunology research
Cancer ResearchImmunology
2013English

CD8+ T Cell Responses in Metastatic Melanoma Patients Receiving an Adenovirally Antigen Engineered Dendritic Cell Vaccine +/- IFN-α

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2015English

Regulatory T Cell Depletion Enhances Tumor Specific CD8 T-Cell Responses, Elicited by Tumor Antigen NY-ESO-1b in Hepatocellular Carcinoma Patients, in Vitro

International Journal of Oncology
Cancer ResearchOncology
2010English

Intratumoral G100, a TLR4 Agonist, Induces Anti-Tumor Immune Responses and Tumor Regression in Patients With Merkel Cell Carcinoma

Clinical Cancer Research
Cancer ResearchOncology
2018English

GTL001, a Bivalent Therapeutic Vaccine Against Human Papillomavirus 16 and 18, Induces Antigen-Specific CD8+ T Cell Responses Leading to Tumor Regression

PLoS ONE
Multidisciplinary
2017English

A Clinical Study of a Cell-Based MAGE-A3 Active Immunotherapy in Advanced Melanoma Patients

Journal of Cancer
Oncology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy